BMRN · Biomarin Pharmaceutical Inc · Fails to Deliver
$57.23
+0.53 (+0.93%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$11.09B
Shares
193.69M
Volume · Nov 13
1.47M
Avg daily vol (3M)
2.19M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-09 | 97 | $54.89 | $5,324 |
| 2026-10-05 | 38,871 | $57.18 | $2,222,644 |
| 2026-09-30 | 260 | $59.87 | $15,566 |
| 2026-09-21 | 823 | $63.94 | $52,623 |
| 2026-09-18 | 23,037 | $65.08 | $1,499,248 |
| 2026-09-17 | 861 | $64.73 | $55,733 |
| 2026-09-02 | 47,834 | $64.84 | $3,101,557 |
| 2026-08-24 | 260 | $66.70 | $17,342 |
Showing 1–8 of 8 settlements
Key facts
CIK
1048477
CUSIP
09061G101
13F (30d)
453 filings
397 filers
Visit website
Investor relations